Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches

Osteosarcomas are the most common malignant bone tumors, and the identification of useful tumor biomarkers and target proteins is required to predict the clinical outcome of patients and therapeutic response as well as to develop novel therapeutic strategies. Global protein expression studies, namel...

Full description

Bibliographic Details
Main Authors: Yoshiyuki Suehara, Daisuke Kubota, Kazutaka Kikuta, Kazuo Kaneko, Akira Kawai, Tadashi Kondo
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Sarcoma
Online Access:http://dx.doi.org/10.1155/2012/425636
id doaj-e31a5860264b45c9a006e9c8055514eb
record_format Article
spelling doaj-e31a5860264b45c9a006e9c8055514eb2020-11-24T22:23:45ZengHindawi LimitedSarcoma1357-714X1369-16432012-01-01201210.1155/2012/425636425636Discovery of Biomarkers for Osteosarcoma by Proteomics ApproachesYoshiyuki Suehara0Daisuke Kubota1Kazutaka Kikuta2Kazuo Kaneko3Akira Kawai4Tadashi Kondo5Department of Orthopedic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, JapanDepartment of Orthopedic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, JapanDepartment of Orthopedic Surgery, Tachikawa Memorial Hospital, 4-2-22 Nishikichou, Tachikawa, Tokyo 190-8531, JapanDepartment of Orthopedic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, JapanDivision of Musculoskeletal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, JapanDivision of Pharmacoproteomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, JapanOsteosarcomas are the most common malignant bone tumors, and the identification of useful tumor biomarkers and target proteins is required to predict the clinical outcome of patients and therapeutic response as well as to develop novel therapeutic strategies. Global protein expression studies, namely, proteomic studies, can offer important clues to understanding the tumor biology that cannot be obtained by other approaches. These studies, such as two-dimensional gel electrophoresis and mass spectrometry, have provided protein expression profiles of osteosarcoma that can be used to develop novel diagnostic and therapeutic biomarkers, as well as to understand biology of tumor progression and malignancy. In this paper, a brief description of the methodology will be provided followed by a few examples of the recent proteomic studies that have generated new information regarding osteosarcomas.http://dx.doi.org/10.1155/2012/425636
collection DOAJ
language English
format Article
sources DOAJ
author Yoshiyuki Suehara
Daisuke Kubota
Kazutaka Kikuta
Kazuo Kaneko
Akira Kawai
Tadashi Kondo
spellingShingle Yoshiyuki Suehara
Daisuke Kubota
Kazutaka Kikuta
Kazuo Kaneko
Akira Kawai
Tadashi Kondo
Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
Sarcoma
author_facet Yoshiyuki Suehara
Daisuke Kubota
Kazutaka Kikuta
Kazuo Kaneko
Akira Kawai
Tadashi Kondo
author_sort Yoshiyuki Suehara
title Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
title_short Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
title_full Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
title_fullStr Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
title_full_unstemmed Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
title_sort discovery of biomarkers for osteosarcoma by proteomics approaches
publisher Hindawi Limited
series Sarcoma
issn 1357-714X
1369-1643
publishDate 2012-01-01
description Osteosarcomas are the most common malignant bone tumors, and the identification of useful tumor biomarkers and target proteins is required to predict the clinical outcome of patients and therapeutic response as well as to develop novel therapeutic strategies. Global protein expression studies, namely, proteomic studies, can offer important clues to understanding the tumor biology that cannot be obtained by other approaches. These studies, such as two-dimensional gel electrophoresis and mass spectrometry, have provided protein expression profiles of osteosarcoma that can be used to develop novel diagnostic and therapeutic biomarkers, as well as to understand biology of tumor progression and malignancy. In this paper, a brief description of the methodology will be provided followed by a few examples of the recent proteomic studies that have generated new information regarding osteosarcomas.
url http://dx.doi.org/10.1155/2012/425636
work_keys_str_mv AT yoshiyukisuehara discoveryofbiomarkersforosteosarcomabyproteomicsapproaches
AT daisukekubota discoveryofbiomarkersforosteosarcomabyproteomicsapproaches
AT kazutakakikuta discoveryofbiomarkersforosteosarcomabyproteomicsapproaches
AT kazuokaneko discoveryofbiomarkersforosteosarcomabyproteomicsapproaches
AT akirakawai discoveryofbiomarkersforosteosarcomabyproteomicsapproaches
AT tadashikondo discoveryofbiomarkersforosteosarcomabyproteomicsapproaches
_version_ 1725764059867906048